DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $954 | +3.5% | 3,844 | +0.0% | 0.08% | +3.9% |
| Q2 2023 | $922 | -4.2% | 3,843 | +0.7% | 0.08% | -8.3% |
| Q1 2023 | $962 | -6.4% | 3,817 | -1.4% | 0.08% | -10.6% |
| Q4 2022 | $1,028 | -99.9% | 3,872 | +1.5% | 0.09% | -3.1% |
| Q3 2022 | $985,000 | +1.9% | 3,814 | 0.0% | 0.10% | +9.0% |
| Q2 2022 | $967,000 | -13.6% | 3,814 | 0.0% | 0.09% | +1.1% |
| Q1 2022 | $1,119,000 | -11.5% | 3,814 | -0.8% | 0.09% | -10.2% |
| Q4 2021 | $1,265,000 | -58.6% | 3,844 | -61.7% | 0.10% | -61.9% |
| Q3 2021 | $3,058,000 | +168.5% | 10,044 | +136.7% | 0.26% | +182.4% |
| Q2 2021 | $1,139,000 | +16.6% | 4,244 | -2.2% | 0.09% | +8.3% |
| Q1 2021 | $977,000 | +1.3% | 4,339 | 0.0% | 0.08% | -9.7% |
| Q4 2020 | $964,000 | +3.2% | 4,339 | 0.0% | 0.09% | -8.8% |
| Q3 2020 | $934,000 | +3.5% | 4,339 | -14.9% | 0.10% | -6.4% |
| Q2 2020 | $902,000 | +18.8% | 5,099 | -7.0% | 0.11% | +10.1% |
| Q1 2020 | $759,000 | -15.1% | 5,484 | -5.8% | 0.10% | +11.2% |
| Q4 2019 | $894,000 | +6.3% | 5,824 | 0.0% | 0.09% | -9.2% |
| Q3 2019 | $841,000 | -7.6% | 5,824 | -8.6% | 0.10% | -8.4% |
| Q2 2019 | $910,000 | +1.8% | 6,369 | -5.9% | 0.11% | +1.9% |
| Q1 2019 | $894,000 | +28.1% | 6,769 | 0.0% | 0.10% | +12.9% |
| Q4 2018 | $698,000 | -4.4% | 6,769 | +0.7% | 0.09% | +8.1% |
| Q3 2018 | $730,000 | +29.4% | 6,719 | +17.5% | 0.09% | +21.1% |
| Q2 2018 | $564,000 | +0.7% | 5,719 | 0.0% | 0.07% | -1.4% |
| Q1 2018 | $560,000 | -68.6% | 5,719 | -70.2% | 0.07% | -62.9% |
| Q4 2017 | $1,783,000 | +12.3% | 19,207 | +3.8% | 0.19% | +7.8% |
| Q3 2017 | $1,588,000 | +55.2% | 18,507 | +52.7% | 0.18% | +55.2% |
| Q2 2017 | $1,023,000 | +60.1% | 12,119 | +62.3% | 0.12% | +56.8% |
| Q1 2017 | $639,000 | -21.4% | 7,469 | -28.5% | 0.07% | -24.5% |
| Q4 2016 | $813,000 | +5.9% | 10,450 | +6.6% | 0.10% | +4.3% |
| Q3 2016 | $768,000 | -22.1% | 9,802 | +0.4% | 0.09% | -25.4% |
| Q2 2016 | $986,000 | -15.7% | 9,764 | -20.7% | 0.13% | -16.0% |
| Q1 2016 | $1,169,000 | +1.9% | 12,319 | -0.2% | 0.15% | +2.7% |
| Q4 2015 | $1,147,000 | -14.0% | 12,346 | -21.1% | 0.15% | -17.0% |
| Q3 2015 | $1,334,000 | -0.4% | 15,655 | 0.0% | 0.18% | +13.5% |
| Q2 2015 | $1,340,000 | +1.4% | 15,655 | +0.5% | 0.16% | 0.0% |
| Q1 2015 | $1,322,000 | -8.5% | 15,574 | -7.6% | 0.16% | -10.4% |
| Q4 2014 | $1,445,000 | +11.7% | 16,860 | -1.0% | 0.17% | +9.5% |
| Q3 2014 | $1,294,000 | +332.8% | 17,032 | +347.7% | 0.16% | +315.8% |
| Q2 2014 | $299,000 | -15.1% | 3,804 | -19.1% | 0.04% | -20.8% |
| Q1 2014 | $352,000 | -13.9% | 4,700 | -11.3% | 0.05% | -14.3% |
| Q4 2013 | $409,000 | +11.4% | 5,300 | 0.0% | 0.06% | +3.7% |
| Q3 2013 | $367,000 | +1.7% | 5,300 | -7.0% | 0.05% | -8.5% |
| Q2 2013 | $361,000 | – | 5,700 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |